Neoplas Control GmbH

Neoplas Control GmbH is an SME in Greifswald, Germany that has taken part in 2 EU-funded projects since 2012, receiving €228k in EU funding.

EU funding received€228k
EU projects2
As coordinator0
Running now1
First EU project2012
Latest project2026
CountryGermany
EU registration (PIC)955820444
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Neoplas Control GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€228k · 1 project
  • Horizon Europe€0 · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • SiCPICAssociated partner

    Silicon carbide photonic integrated circuit training network

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • MIRIFISENSPartner

    Mid InfraRed Innovative lasers For Improved SENSor of hazardous substances

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €228ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • coating and films
  • infrared astronomy
  • inorganic compounds
  • laser physics
  • metalloids
  • nanotechnology
  • semiconductivity
  • sensors
  • spectroscopy

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime